Cardiovascular Disease (CVD) Completed Phase 4 Trials for Atorvastatin (DB01076)

Also known as: Cardiovascular Heart Disease / Cardiovascular Disease (CKD) / Cardiovascular (CV) Disease / Cardiovascular Disease / Cardiovascular Diseases

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00147602Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous StrokeTreatment
NCT00327691A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target LevelsPrevention
NCT00441597Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?Treatment
NCT00522158Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition
NCT00632840Pharmacological Regulation of Fat Transport in Metabolic SyndromeTreatment
NCT00701220Statin Therapy for Ischemic and Nonischemic CardiomyopathyTreatment
NCT01285544The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With HypercholesterolemiaTreatment
NCT02781064STATIN: Web-based Investigation of Side EffectsOther
NCT00159835Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHDTreatment
NCT03073863Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets StudyPrevention